The Pharma Market Access Pricing and Reimbursement Conference 2013

The Pharma Market Access Pricing and Reimbursement Conference 2013 is dedicated to developments impacting the future of pharmaceutical reimbursement and pricing, including:

• Implementation of market access strategies during early development stages
• Evidence development for reimbursement and market access
• The impact of comparative effectiveness research on reimbursement
• Alternative (shared risk) pricing schemes in theory and practice
• Value-based pricing and its future
• Partnering with payers and providers
• Case studies of various pricing schemes in action
• Health Technology Assessments (HTAs)
• The coming implementation of the PPACA and its impact on public reimbursement schemes
• Integration of payer requirements into product development
• Collection and analysis of reimbursement evidence
• Quantification of economic value

Who should Attend

Attendees interested in pharmaceutical pricing and reimbursement with responsibilities in:

• Chief Medical Officers
• Business Development
• Commercialization
• Chief Pharmacy Officers
• Comparative Effectiveness
• Commercial Operations
• Government, Payer & Stakeholder Relations
• Evidence-Based Medicine
• Health Outcomes
• Health Economics
• HTA
• Health Policy
• Market Access
• Managed Markets
• Medical Affairs
• Marketing
• New Product Planning
• National Accounts
• Pricing & Reimbursement
• Portfolio Management
• Reimbursement
• Product /Brand Management
• Strategic Accounts
• Sales
• Strategic Pricing